Overcoming the myths of esketamine administration: different and not difficult
Frontiers in Psychiatry, 2023 Intranasal esketamine for treatment-resistant depression has been introduced and approved by the FDA and EMA in 2019 and 2020, respectively. Since then, the administration practices were found different among countries. Major depression has a high impact
Florian Buchmayer, Siegfried Kasper
doaj +1 more source
Inter and intra-hemispheric structural imaging markers predict depression relapse after electroconvulsive therapy: a multisite study. [PDF]
, 2017 Relapse of depression following treatment is high. Biomarkers predictive of an individual's relapse risk could provide earlier opportunities for prevention.
Abbott, Christopher C +8 more
core +3 more sources
Next MaterialsMolecular dynamics (MD) and Monte Carlo (MC) simulations are used to study the microstructural evolution of FeCoNiCrMn high-entropy alloys (HEA) after laser shock peening (LSP).
Weizhou Xu +3 more
doaj +1 more source
Treatment-resistant anxiety disorders [PDF]
Molecular Psychiatry, 2006 Several epidemiological studies confirmed that Anxiety Disorders as a group are the most prevalent psychiatric conditions in the United States. The importance of these conditions is underlined by the fact that they cause significant disability, poor quality of life, alcohol and drug abuse.
openaire +2 more sources
Electroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depression. [PDF]
, 2014 Whether plasticity of white matter (WM) microstructure relates to therapeutic response in major depressive disorder (MDD) remains uncertain. We examined diffusion tensor imaging (DTI) correlates of WM structural connectivity in patients receiving ...
Clark, K +7 more
core +1 more source
Medicaid spending burden among beneficiaries with treatment-resistant depression. [PDF]
, 2019 AIM: To evaluate Medicaid spending and healthcare resource utilization (HRU) in treatment-resistant depression (TRD). MATERIALS & METHODS: TRD beneficiaries were identified from Medicaid claims databases (January 2010-March 2017) and matched 1:1 with ...
Greenberg, Paul E. +7 more
core +1 more source
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms [PDF]
, 2017 Psilocybin with psychological support is showing promise as a treatment model in psychiatry but its therapeutic mechanisms are poorly understood.
Bolstridge, Mark +12 more
core +4 more sources
Pediatric Blood &Cancer, EarlyView.ABSTRACT Ongoing evidence indicates increased risk of sarcopenic obesity among children and young people (CYP) with acute lymphoblastic leukemia (ALL), often beginning early in treatment, persisting into survivorship. This review evaluates current literature on body composition in CYP with ALL during and after treatment.
Lina A. Zahed +5 more
wiley +1 more source
White matter tract integrity in treatment-resistant gambling disorder. [PDF]
, 2016 BACKGROUND: Gambling disorder is a relatively common psychiatric disorder recently re-classified within the DSM-5 under the category of 'substance-related and addictive disorders'.
Chamberlain, Samuel R +5 more
core +5 more sources
Maintenance deep transcranial magnetic stimulation sessions are associated with reduced depressive relapses in patients with unipolar or bipolar depression [PDF]
, 2015 Introduction: Deep transcranial magnetic stimulation (dTMS) is a new form of TMS allowing safe stimulation of deep brain regions. The objective of this preliminary study was to assess the role of dTMS maintenance sessions in protecting patients with ...
ANGELETTI, Gloria +11 more
core +2 more sources